Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
Operating expenses:
General and administrative (including stock-based compensation (Note 9))	$ 550,095	$ 333,196	$ 1,058,000	$ 690,537
Depreciation	76,083	127,159	151,962	312,043
Research and development (including stock-based compensation (Note 9))	84,286	104,237	218,775	170,823
Total operating expenses	710,464	564,592	1,428,737	1,173,403
Loss from operations	(710,464)	(564,592)	(1,428,737)	(1,173,403)
Other expense:
Interest expense, net	86,405	100,356	200,661	197,303
Total other expense	86,405	100,356	200,661	197,303
Net loss	(796,869)	(664,948)	(1,629,398)	(1,370,706)
Net loss attributable to the noncontrolling interest	1,274	1,028	2,569	2,099
Net loss attributable to Bion	(795,595)	(663,920)	(1,626,829)	(1,368,607)
Dividends on preferred stock	(500)	(500)	(1,000)	(1,000)
Net loss applicable to Bion's common stockholders	$ (796,095)	$ (664,420)	$ (1,627,829)	$ (1,369,607)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in dollars per share)	$ (0.03)	$ (0.03)	$ (0.07)	$ (0.07)
Weighted-average number of common shares outstanding:
Basic and diluted (in shares)	22,585,001	19,965,459	22,437,039	19,891,267